AUROBINDO PHARMA LTD FDA Approval ANDA 213286

ANDA 213286

AUROBINDO PHARMA LTD

FDA Drug Application

Application #213286

Application Sponsors

ANDA 213286AUROBINDO PHARMA LTD

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORALEQ 10MG BASE0FLUOXETINE HYDROCHLORIDEFLUOXETINE HYDROCHLORIDE
002TABLET;ORALEQ 20MG BASE0FLUOXETINE HYDROCHLORIDEFLUOXETINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2020-04-08STANDARD
LABELING; LabelingSUPPL2AP2021-09-20STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

AUROBINDO PHARMA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213286
            [companyName] => AUROBINDO PHARMA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"FLUOXETINE HYDROCHLORIDE","activeIngredients":"FLUOXETINE HYDROCHLORIDE","strength":"EQ 10MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"FLUOXETINE HYDROCHLORIDE","activeIngredients":"FLUOXETINE HYDROCHLORIDE","strength":"EQ 20MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/08\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-04-08
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.